Annie McGuire, the SVP of $VCYT, sold 6,466 shares of the company on 11-05-2025 for an estimated $258,640. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.2% of their shares of this class of stock. Following this trade, they now own 82,973 shares of this class of $VCYT stock.
$VCYT Insider Trading Activity
$VCYT insiders have traded $VCYT stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $VCYT stock by insiders over the last 6 months:
- EVAN/ FA JONES has made 0 purchases and 6 sales selling 43,196 shares for an estimated $1,946,287.
- KARIN EASTHAM has made 0 purchases and 2 sales selling 14,264 shares for an estimated $509,578.
- ANNIE MCGUIRE (SVP, General Counsel) has made 0 purchases and 2 sales selling 8,749 shares for an estimated $335,559.
- PHILLIP G. FEBBO (Chief Scientific & Med Officer) sold 8,349 shares for an estimated $300,709
- REBECCA CHAMBERS (Chief Financial Officer) sold 7,000 shares for an estimated $287,000
- MARC STAPLEY (Chief Executive Officer) sold 7,667 shares for an estimated $233,132
- MUNA BHANJI sold 4,589 shares for an estimated $122,366
- JOHN LEITE (Chief Commercial Officer-CLIA) sold 2,809 shares for an estimated $76,409
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VCYT Hedge Fund Activity
We have seen 163 institutional investors add shares of $VCYT stock to their portfolio, and 141 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 1,351,370 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $36,527,531
- ARTISAN PARTNERS LIMITED PARTNERSHIP added 1,082,064 shares (+20.7%) to their portfolio in Q2 2025, for an estimated $29,248,189
- FMR LLC added 1,007,331 shares (+14.2%) to their portfolio in Q2 2025, for an estimated $27,228,156
- ASSENAGON ASSET MANAGEMENT S.A. removed 803,061 shares (-96.7%) from their portfolio in Q3 2025, for an estimated $27,569,084
- SQUAREPOINT OPS LLC added 794,307 shares (+770.6%) to their portfolio in Q2 2025, for an estimated $21,470,118
- CATALIO CAPITAL MANAGEMENT, LP removed 762,225 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $20,602,941
- SOLEUS CAPITAL MANAGEMENT, L.P. added 715,439 shares (+inf%) to their portfolio in Q2 2025, for an estimated $19,338,316
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$VCYT Congressional Stock Trading
Members of Congress have traded $VCYT stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $VCYT stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 06/16.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$VCYT Analyst Ratings
Wall Street analysts have issued reports on $VCYT in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 11/05/2025
- Freedom Capital Markets issued a "Buy" rating on 10/17/2025
To track analyst ratings and price targets for $VCYT, check out Quiver Quantitative's $VCYT forecast page.
$VCYT Price Targets
Multiple analysts have issued price targets for $VCYT recently. We have seen 5 analysts offer price targets for $VCYT in the last 6 months, with a median target of $45.0.
Here are some recent targets:
- Mike Matson from Needham set a target price of $44.0 on 11/05/2025
- Subbu Nambi from Guggenheim set a target price of $45.0 on 11/05/2025
- Lu Li from UBS set a target price of $48.0 on 11/05/2025
- Kyle Mikson from Canaccord Genuity set a target price of $43.0 on 11/05/2025
- Keith Hinton from Freedom Capital Markets set a target price of $45.0 on 10/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
